NASDAQ: NDRA
Endra Life Sciences Inc Stock Forecast, Predictions & Price Target

Analyst price target for NDRA

Based on 1 analyst offering 12 month price targets for Endra Life Sciences Inc

Min Forecast
$50.00+1,520.75%
Avg Forecast
$50.00+1,520.75%
Max Forecast
$50.00+1,520.75%

Should I buy or sell NDRA stock?

Based on 1 analyst offering ratings for Endra Life Sciences Inc.

Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NDRA stock forecasts and price targets.

NDRA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-04-21

1 of 1

Forecast return on equity

Is NDRA forecast to generate an efficient return?

Company
-337.72%
Industry
-7.84%
Market
46.36%
NDRA's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is NDRA forecast to generate an efficient return on assets?

Company
-194.21%
Industry
8.91%
NDRA is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

NDRA earnings per share forecast

What is NDRA's earnings per share in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$15.38

NDRA revenue forecast

What is NDRA's revenue in the next 1 years based on estimates from 1 analyst?

Avg 1 year Forecast
$10.0k

NDRA vs Diagnostic & Research Stocks

TickerPricePrice TargetUp/downsideConsensus
NDRA$3.09$50.00+1,520.75%Buy
APDN$0.90N/AN/A
ISPC$1.20N/AN/A
CHEK$0.65N/AN/A
XWEL$0.76N/AN/A

Endra Life Sciences Stock Forecast FAQ

Is Endra Life Sciences Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NDRA) stock is to Buy NDRA stock.

Out of 1 analyst, 0 (0%) are recommending NDRA as a Strong Buy, 1 (100%) are recommending NDRA as a Buy, 0 (0%) are recommending NDRA as a Hold, 0 (0%) are recommending NDRA as a Sell, and 0 (0%) are recommending NDRA as a Strong Sell.

If you're new to stock investing, here's how to buy Endra Life Sciences stock.

What is NDRA's earnings growth forecast for 2025-2025?

(NASDAQ: NDRA) Endra Life Sciences's forecast annual earnings growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast earnings growth rate of N/A, and while it is not forecast to beat the US market's average forecast earnings growth rate of N/A.

Endra Life Sciences's earnings in 2025 is -$11,507,947.

In 2025, NDRA is forecast to generate -$8,646,836 in earnings, with the lowest earnings forecast at -$8,646,836 and the highest earnings forecast at -$8,646,836.

What is NDRA's revenue growth forecast for 2025-2025?

(NASDAQ: NDRA) Endra Life Sciences's forecast annual revenue growth rate of N/A is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Endra Life Sciences's revenue in 2025 is $0.

In 2025, NDRA is forecast to generate $5,622 in revenue, with the lowest revenue forecast at $5,622 and the highest revenue forecast at $5,622.

What is NDRA's forecast return on assets (ROA) for 2025-2025?

(NASDAQ: NDRA) forecast ROA is -194.21%, which is lower than the forecast US Diagnostics & Research industry average of 8.91%.

What is NDRA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NDRA price target, the average NDRA price target is $50.00, with the highest NDRA stock price forecast at $50.00 and the lowest NDRA stock price forecast at $50.00.

The Wall Street analyst predicted that Endra Life Sciences's share price could reach $50.00 by Apr 21, 2026. The average Endra Life Sciences stock price prediction forecasts a potential upside of 1,520.75% from the current NDRA share price of $3.09.

What is NDRA's Earnings Per Share (EPS) forecast for 2025-2025?

(NASDAQ: NDRA) Endra Life Sciences's current Earnings Per Share (EPS) is -$56.94. In 2025, NDRA's EPS is forecast to hit -$15.38 (min: -$15.38, max: -$15.38).

What is NDRA's forecast return on equity (ROE) for 2025-2025?

(NASDAQ: NDRA) forecast ROE is -337.72%, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.